Freehold, NJ March 14, 2011 (Lifeblood Medical, Inc.)
Lifeblood Medical, Inc. has been notified that it has received approval in India for a patent related to its proprietary technology. Entitled “Composition for Maintaining Organ and Cell Viability”, both Lifor® and LiforCell®1 are protected under this patent.
The Lifeblood Patent Portfolio now includes United States, Australia, India, Mexico and South Africa.
About Lifeblood Medical, Inc.
Lifeblood Medical, Inc., with headquarters in Adelphia, New Jersey, is dedicated to enhancing the gift of life through our innovative patented technology. The Company’s patented Lifor® products are focused on (1) extending organ preservation via room temperature, (2) limb preservation and (3) oxygen therapeutics. Lifeblood’s commitment to innovation continues with expansion of the applications of Lifor® through research and development.
General Inquiries
Joseph Fischer
President and CEO, Lifeblood Medical, Inc.
732-431-5833
| 
